For the Inventor, By the Inventor

Enter assignee name

Los Angeles, CA, United States of America

Kalypsys, Inc.

USPTO Granted Patents = 17

% Expired Patents = 64.7

EPO Patents = 3

Trademarks = 5

Forward Citations = 56

Loading Chart...

Loading Chart...

42 inventors (with patents filed for the assignee):

Stewart Alwyn Noble (14 out of 27 patents)

Andrew Shiau (8 out of 18 patents)

James W Malecha (8 out of 41 patents)

4. Steven P Govek (7 out of 34 patents)

5. David J Thomas (5 out of 5 patents)

6. Sergio G Duron (4 out of 17 patents)

7. Mehmet Kahraman (4 out of 34 patents)

8. Andrew K Lindstrom (4 out of 4 patents)

9. Christian Andreus Hassig (4 out of 8 patents)

10. Christopher D Bayne (3 out of 6 patents)

11. Guy Oshiro (3 out of 3 patents)

12. Cunxiang Zhao (3 out of 3 patents)

13. Carmen K Robinson (3 out of 3 patents)

14. Boliang Lou (3 out of 8 patents)

15. Michael Sertic (3 out of 3 patents)

17 patents: Sort by Forward Citations

1. 9078887 - Bicyclic heteroaryl inhibitors of PDE4 (2015-07-14),

2. 8859550 - Heterocyclic inhibitors of histamine receptors for the treatment of disease (2014-10-14),

3. 8569300 - Substituted tetrazolo[1,5-A]pyrazine inhibitors of histamine receptors for the treatment of disease (2013-10-29),

4. 8258154 - Bicyclic heteroaryl inhibitors of PDE4 (2012-09-04),

5. 8138205 - Heteroarylalkoxy-substituted quinolone inhibitors of PDE4 (2012-03-20),

6. 8080566 - Carbazole inhibitors of histamine receptors for the treatment of disease (2011-12-20),

7. 8080563 - Bicyclic heteroaryl inhibitors of PDE4 (2011-12-20),

8. 7915253 - Sulfonyl-substituted bicyclic compounds as modulators of PPAR (2011-03-29),

9. 7863276 - Salts of modulators of PPAR and methods of treating metabolic disorders (2011-01-04),

10. 7834004 - Sulfonyl-substituted bicyclic compounds as modulators of PPAR (2010-11-16),

11. 7825256 - Inducible nitric oxide synthase dimerization inhibitors (2010-11-02),

12. 7745646 - Bicyclic heteroaryl inhibitors of PDE4 (2010-06-29),

13. 7517884 - Sulfonyl-substituted bicyclic compounds as modulators of PPAR (2009-04-14),

14. 7494999 - Sulfonyl-substituted bicyclic compounds as modulators of PPAR (2009-02-24),

15. 7470722 - Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease (2008-12-30),

Company Overview

Kalypsys, Inc. is a biotechnology company based in Los Angeles, California, specializing in the development of innovative solutions for drug discovery and development. The organization focuses on leveraging advanced technologies to enhance the efficiency of pharmaceutical research, particularly in the areas of high-throughput screening and assay development. Kalypsys aims to streamline the process of identifying and optimizing potential therapeutic candidates, contributing to advancements in various therapeutic areas.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

17 Patents

#118 in Los Angeles, CA

#4,518 in California

#18,903 in US

#35,948 in the World

Los Angeles, CA, United States of America

Kalypsys, Inc.

Forward Citations = 56

42 inventors:

Stewart Alwyn Noble (14 out of 27 patents)

Andrew Shiau (8 out of 18 patents)

James W Malecha (8 out of 41 patents)

4. Steven P Govek (7 out of 34 patents)

5. David J Thomas (5 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Kalypsys, Inc.. Retrieved from https://idiyas.com/company/kalypsys

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…